APLN and prostate carcinoma: Additionally, apelin-induced inhibition of miR-8070 synthesis was reversed by blocking ERK, p38, and JNK expression, indicating that apelin regulates integrin production and cell motility in prostate cancer by reducing miR-8070 levels through the MAPK pathway.